日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma

低甲基化的表观遗传启动增强了 Tolinapant 在 T 细胞淋巴瘤中的免疫原性潜力

George A Ward, Zhiqiang Zhang, Simone Jueliger, Ilya S Potapov, Matthew P Davis, Adam R Boxall, Jason Taylor, Harold Keer, Andrea Biondo, John F Lyons, Martin Sims, Tomoko Smyth

Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma

拮抗凋亡抑制蛋白揭示了一种基于免疫反应的新型T细胞淋巴瘤治疗方法。

Ferrari, Nicola; Ward, George; Gewinner, Christina; Davis, Matthew P; Jueliger, Simone; Saini, Harpreet; Munck, Joanne; Smyth, Tomoko; Ferraldeschi, Roberta; Keer, Harold; Lyons, John; Sims, Martin J

A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer

一项随机II期临床试验,研究表观遗传学启动联合卡铂治疗铂耐药复发性卵巢癌的疗效

Oza, Amit M; Matulonis, Ursula A; Alvarez Secord, Angeles; Nemunaitis, John; Roman, Lynda D; Blagden, Sarah P; Banerjee, Susana; McGuire, William P; Ghamande, Sharad; Birrer, Michael J; Fleming, Gini F; Markham, Merry Jennifer; Hirte, Hal W; Provencher, Diane M; Basu, Bristi; Kristeleit, Rebecca; Armstrong, Deborah K; Schwartz, Benjamin; Braly, Patricia; Hall, Geoff D; Nephew, Kenneth P; Jueliger, Simone; Oganesian, Aram; Naim, Sue; Hao, Yong; Keer, Harold; Azab, Mohammad; Matei, Daniela

First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

AT13148(一种双重 ROCK-AKT 抑制剂)在实体瘤患者中的首次人体研究

McLeod, Robert; Kumar, Rajiv; Papadatos-Pastos, Dionysis; Mateo, Joaquin; Brown, Jessica S; Garces, Alvaro H Ingles; Ruddle, Ruth; Decordova, Shaun; Jueliger, Simone; Ferraldeschi, Roberta; Maiques, Oscar; Sanz-Moreno, Victoria; Jones, Paul; Traub, Stephanie; Halbert, Gavin; Mellor, Sarah; Swales, Karen E; Raynaud, Florence I; Garrett, Michelle D; Banerji, Udai

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

一项针对阿扎胞苷治疗失败后高危骨髓增生异常综合征和低原始细胞计数急性髓系白血病患者的 guadecitabine II 期研究。

Sébert, Marie; Renneville, Aline; Bally, Cécile; Peterlin, Pierre; Beyne-Rauzy, Odile; Legros, Laurence; Gourin, Marie-Pierre; Sanhes, Laurence; Wattel, Eric; Gyan, Emmanuel; Park, Sophie; Stamatoullas, Aspasia; Banos, Anne; Laribi, Kamel; Jueliger, Simone; Bevan, Luke; Chermat, Fatiha; Sapena, Rosa; Nibourel, Olivier; Chaffaut, Cendrine; Chevret, Sylvie; Preudhomme, Claude; Adès, Lionel; Fenaux, Pierre

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

新型DNA低甲基化药物guadecitabine (SGI-110)在肝细胞癌临床前模型中的疗效和表观遗传相互作用

Jueliger, Simone; Lyons, John; Cannito, Sara; Pata, Illar; Pata, Pille; Shkolnaya, Marianna; Lo Re, Oriana; Peyrou, Marion; Villarroya, Francesc; Pazienza, Valerio; Rappa, Francesca; Cappello, Francesco; Azab, Mohammad; Taverna, Pietro; Vinciguerra, Manlio

Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing

地西他滨治疗胶质瘤起始细胞可增强免疫识别和杀伤力

Cristina Riccadonna, Céline Yacoub Maroun, Romain Vuillefroy de Silly, Margaux Boehler, Marta Calvo Tardón, Simone Jueliger, Pietro Taverna, Leticia Barba, Eliana Marinari, Serena Pellegatta, Esen Yonca Bassoy, Denis Martinvalet, Pierre-Yves Dietrich, Paul R Walker